Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
63
GTII.CX Quote, Financials, Valuation and Earnings
Last price:
$10.60
Seasonality move
:
25.78%
Day range:
$9.85 - $11.29
52-week range:
$6.54 - $14.39
Dividend yield:
0%
P/E ratio:
41.09x
P/S ratio:
1.55x
P/B ratio:
0.97x
Volume:
417.9K
Avg. volume:
310.2K
1-year change:
-5.61%
Market cap:
$2.5B
Revenue:
$1.6B
EPS (TTM):
$0.26
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
GTII.CX
Green Thumb Industries, Inc.
|
$405.6M | $0.05 | -1.05% | -100% | $17.51 |
|
DRUG.CX
Bright Minds Biosciences, Inc.
|
-- | -$1.00 | -- | -483.33% | $89.67 |
|
FFNT.CX
4Front Ventures Corp.
|
-- | -- | -- | -- | -- |
|
LOWL.CX
Lowell Farms, Inc.
|
-- | -- | -- | -- | -- |
|
VREO.CX
Vireo Growth, Inc.
|
$130.5M | -- | 277.31% | -- | -- |
|
WESA.X.CX
Wesana Health Holdings
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
GTII.CX
Green Thumb Industries, Inc.
|
$10.60 | $17.51 | $2.5B | 41.09x | $0.00 | 0% | 1.55x |
|
DRUG.CX
Bright Minds Biosciences, Inc.
|
$115.56 | $89.67 | $819.2M | -- | $0.00 | 0% | -- |
|
FFNT.CX
4Front Ventures Corp.
|
$0.0050 | -- | $4.6M | -- | $0.00 | 0% | 0.04x |
|
LOWL.CX
Lowell Farms, Inc.
|
$0.02 | -- | $272.2K | -- | $0.00 | 0% | 0.01x |
|
VREO.CX
Vireo Growth, Inc.
|
$0.79 | -- | $750.3M | -- | $0.00 | 0% | 1.58x |
|
WESA.X.CX
Wesana Health Holdings
|
$0.0100 | -- | $200.8K | -- | $0.00 | 0% | 0.39x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
GTII.CX
Green Thumb Industries, Inc.
|
22.08% | 0.998 | 27.9% | 1.19x |
|
DRUG.CX
Bright Minds Biosciences, Inc.
|
0.27% | 3.206 | 0.06% | 84.94x |
|
FFNT.CX
4Front Ventures Corp.
|
338.18% | 2.441 | 156.19% | 0.11x |
|
LOWL.CX
Lowell Farms, Inc.
|
-- | 1.953 | -- | 0.35x |
|
VREO.CX
Vireo Growth, Inc.
|
45.27% | -3.608 | 33.16% | 0.56x |
|
WESA.X.CX
Wesana Health Holdings
|
-- | -3.241 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
GTII.CX
Green Thumb Industries, Inc.
|
$189.3M | $50.6M | 1.96% | 2.53% | 12.61% | $78.2M |
|
DRUG.CX
Bright Minds Biosciences, Inc.
|
-$15.8K | -$3.3M | -25.1% | -25.19% | -- | -$3.5M |
|
FFNT.CX
4Front Ventures Corp.
|
$5M | -$8.9M | -137.74% | -- | -25.23% | -$770.6K |
|
LOWL.CX
Lowell Farms, Inc.
|
-$1.3M | -$2.9M | -130.79% | -182.5% | -99.38% | -$1.2M |
|
VREO.CX
Vireo Growth, Inc.
|
$48.6M | $2.2M | -25.61% | -52.07% | 1.76% | -$30.9M |
|
WESA.X.CX
Wesana Health Holdings
|
-- | -- | -- | -- | -- | -- |
Green Thumb Industries, Inc. vs. Competitors
-
Which has Higher Returns GTII.CX or DRUG.CX?
Bright Minds Biosciences, Inc. has a net margin of 8.17% compared to Green Thumb Industries, Inc.'s net margin of --. Green Thumb Industries, Inc.'s return on equity of 2.53% beat Bright Minds Biosciences, Inc.'s return on equity of -25.19%.
Company Gross Margin Earnings Per Share Invested Capital GTII.CXGreen Thumb Industries, Inc.47.18% $0.14 $3.3B DRUG.CXBright Minds Biosciences, Inc.-- -$0.74 $52M -
What do Analysts Say About GTII.CX or DRUG.CX?
Green Thumb Industries, Inc. has a consensus price target of $17.51, signalling upside risk potential of 65.22%. On the other hand Bright Minds Biosciences, Inc. has an analysts' consensus of $89.67 which suggests that it could fall by -22.41%. Given that Green Thumb Industries, Inc. has higher upside potential than Bright Minds Biosciences, Inc., analysts believe Green Thumb Industries, Inc. is more attractive than Bright Minds Biosciences, Inc..
Company Buy Ratings Hold Ratings Sell Ratings GTII.CXGreen Thumb Industries, Inc.9 1 0 DRUG.CXBright Minds Biosciences, Inc.6 0 0 -
Is GTII.CX or DRUG.CX More Risky?
Green Thumb Industries, Inc. has a beta of 0.833, which suggesting that the stock is 16.713% less volatile than S&P 500. In comparison Bright Minds Biosciences, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock GTII.CX or DRUG.CX?
Green Thumb Industries, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Bright Minds Biosciences, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Green Thumb Industries, Inc. pays -- of its earnings as a dividend. Bright Minds Biosciences, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios GTII.CX or DRUG.CX?
Green Thumb Industries, Inc. quarterly revenues are $401.3M, which are larger than Bright Minds Biosciences, Inc. quarterly revenues of --. Green Thumb Industries, Inc.'s net income of $32.8M is higher than Bright Minds Biosciences, Inc.'s net income of -$5.2M. Notably, Green Thumb Industries, Inc.'s price-to-earnings ratio is 41.09x while Bright Minds Biosciences, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Green Thumb Industries, Inc. is 1.55x versus -- for Bright Minds Biosciences, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GTII.CXGreen Thumb Industries, Inc.1.55x 41.09x $401.3M $32.8M DRUG.CXBright Minds Biosciences, Inc.-- -- -- -$5.2M
-
Which has Higher Returns GTII.CX or FFNT.CX?
4Front Ventures Corp. has a net margin of 8.17% compared to Green Thumb Industries, Inc.'s net margin of -37.38%. Green Thumb Industries, Inc.'s return on equity of 2.53% beat 4Front Ventures Corp.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital GTII.CXGreen Thumb Industries, Inc.47.18% $0.14 $3.3B FFNT.CX4Front Ventures Corp.21.39% -$0.01 $27.7M -
What do Analysts Say About GTII.CX or FFNT.CX?
Green Thumb Industries, Inc. has a consensus price target of $17.51, signalling upside risk potential of 65.22%. On the other hand 4Front Ventures Corp. has an analysts' consensus of -- which suggests that it could grow by 2907.29%. Given that 4Front Ventures Corp. has higher upside potential than Green Thumb Industries, Inc., analysts believe 4Front Ventures Corp. is more attractive than Green Thumb Industries, Inc..
Company Buy Ratings Hold Ratings Sell Ratings GTII.CXGreen Thumb Industries, Inc.9 1 0 FFNT.CX4Front Ventures Corp.0 0 0 -
Is GTII.CX or FFNT.CX More Risky?
Green Thumb Industries, Inc. has a beta of 0.833, which suggesting that the stock is 16.713% less volatile than S&P 500. In comparison 4Front Ventures Corp. has a beta of 0.812, suggesting its less volatile than the S&P 500 by 18.786%.
-
Which is a Better Dividend Stock GTII.CX or FFNT.CX?
Green Thumb Industries, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. 4Front Ventures Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Green Thumb Industries, Inc. pays -- of its earnings as a dividend. 4Front Ventures Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios GTII.CX or FFNT.CX?
Green Thumb Industries, Inc. quarterly revenues are $401.3M, which are larger than 4Front Ventures Corp. quarterly revenues of $23.4M. Green Thumb Industries, Inc.'s net income of $32.8M is higher than 4Front Ventures Corp.'s net income of -$8.7M. Notably, Green Thumb Industries, Inc.'s price-to-earnings ratio is 41.09x while 4Front Ventures Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Green Thumb Industries, Inc. is 1.55x versus 0.04x for 4Front Ventures Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GTII.CXGreen Thumb Industries, Inc.1.55x 41.09x $401.3M $32.8M FFNT.CX4Front Ventures Corp.0.04x -- $23.4M -$8.7M
-
Which has Higher Returns GTII.CX or LOWL.CX?
Lowell Farms, Inc. has a net margin of 8.17% compared to Green Thumb Industries, Inc.'s net margin of -111.87%. Green Thumb Industries, Inc.'s return on equity of 2.53% beat Lowell Farms, Inc.'s return on equity of -182.5%.
Company Gross Margin Earnings Per Share Invested Capital GTII.CXGreen Thumb Industries, Inc.47.18% $0.14 $3.3B LOWL.CXLowell Farms, Inc.-28.98% -$0.26 $5.7M -
What do Analysts Say About GTII.CX or LOWL.CX?
Green Thumb Industries, Inc. has a consensus price target of $17.51, signalling upside risk potential of 65.22%. On the other hand Lowell Farms, Inc. has an analysts' consensus of -- which suggests that it could grow by 19875.27%. Given that Lowell Farms, Inc. has higher upside potential than Green Thumb Industries, Inc., analysts believe Lowell Farms, Inc. is more attractive than Green Thumb Industries, Inc..
Company Buy Ratings Hold Ratings Sell Ratings GTII.CXGreen Thumb Industries, Inc.9 1 0 LOWL.CXLowell Farms, Inc.0 0 0 -
Is GTII.CX or LOWL.CX More Risky?
Green Thumb Industries, Inc. has a beta of 0.833, which suggesting that the stock is 16.713% less volatile than S&P 500. In comparison Lowell Farms, Inc. has a beta of 1.815, suggesting its more volatile than the S&P 500 by 81.503%.
-
Which is a Better Dividend Stock GTII.CX or LOWL.CX?
Green Thumb Industries, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Lowell Farms, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Green Thumb Industries, Inc. pays -- of its earnings as a dividend. Lowell Farms, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios GTII.CX or LOWL.CX?
Green Thumb Industries, Inc. quarterly revenues are $401.3M, which are larger than Lowell Farms, Inc. quarterly revenues of $4.4M. Green Thumb Industries, Inc.'s net income of $32.8M is higher than Lowell Farms, Inc.'s net income of -$5M. Notably, Green Thumb Industries, Inc.'s price-to-earnings ratio is 41.09x while Lowell Farms, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Green Thumb Industries, Inc. is 1.55x versus 0.01x for Lowell Farms, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GTII.CXGreen Thumb Industries, Inc.1.55x 41.09x $401.3M $32.8M LOWL.CXLowell Farms, Inc.0.01x -- $4.4M -$5M
-
Which has Higher Returns GTII.CX or VREO.CX?
Vireo Growth, Inc. has a net margin of 8.17% compared to Green Thumb Industries, Inc.'s net margin of -28.69%. Green Thumb Industries, Inc.'s return on equity of 2.53% beat Vireo Growth, Inc.'s return on equity of -52.07%.
Company Gross Margin Earnings Per Share Invested Capital GTII.CXGreen Thumb Industries, Inc.47.18% $0.14 $3.3B VREO.CXVireo Growth, Inc.38.51% -$0.04 $626.2M -
What do Analysts Say About GTII.CX or VREO.CX?
Green Thumb Industries, Inc. has a consensus price target of $17.51, signalling upside risk potential of 65.22%. On the other hand Vireo Growth, Inc. has an analysts' consensus of -- which suggests that it could fall by -17.72%. Given that Green Thumb Industries, Inc. has higher upside potential than Vireo Growth, Inc., analysts believe Green Thumb Industries, Inc. is more attractive than Vireo Growth, Inc..
Company Buy Ratings Hold Ratings Sell Ratings GTII.CXGreen Thumb Industries, Inc.9 1 0 VREO.CXVireo Growth, Inc.0 0 0 -
Is GTII.CX or VREO.CX More Risky?
Green Thumb Industries, Inc. has a beta of 0.833, which suggesting that the stock is 16.713% less volatile than S&P 500. In comparison Vireo Growth, Inc. has a beta of 0.001, suggesting its less volatile than the S&P 500 by 99.895%.
-
Which is a Better Dividend Stock GTII.CX or VREO.CX?
Green Thumb Industries, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Vireo Growth, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Green Thumb Industries, Inc. pays -- of its earnings as a dividend. Vireo Growth, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios GTII.CX or VREO.CX?
Green Thumb Industries, Inc. quarterly revenues are $401.3M, which are larger than Vireo Growth, Inc. quarterly revenues of $126.2M. Green Thumb Industries, Inc.'s net income of $32.8M is higher than Vireo Growth, Inc.'s net income of -$36.2M. Notably, Green Thumb Industries, Inc.'s price-to-earnings ratio is 41.09x while Vireo Growth, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Green Thumb Industries, Inc. is 1.55x versus 1.58x for Vireo Growth, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GTII.CXGreen Thumb Industries, Inc.1.55x 41.09x $401.3M $32.8M VREO.CXVireo Growth, Inc.1.58x -- $126.2M -$36.2M
-
Which has Higher Returns GTII.CX or WESA.X.CX?
Wesana Health Holdings has a net margin of 8.17% compared to Green Thumb Industries, Inc.'s net margin of --. Green Thumb Industries, Inc.'s return on equity of 2.53% beat Wesana Health Holdings's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital GTII.CXGreen Thumb Industries, Inc.47.18% $0.14 $3.3B WESA.X.CXWesana Health Holdings-- -- -- -
What do Analysts Say About GTII.CX or WESA.X.CX?
Green Thumb Industries, Inc. has a consensus price target of $17.51, signalling upside risk potential of 65.22%. On the other hand Wesana Health Holdings has an analysts' consensus of -- which suggests that it could grow by 2383.25%. Given that Wesana Health Holdings has higher upside potential than Green Thumb Industries, Inc., analysts believe Wesana Health Holdings is more attractive than Green Thumb Industries, Inc..
Company Buy Ratings Hold Ratings Sell Ratings GTII.CXGreen Thumb Industries, Inc.9 1 0 WESA.X.CXWesana Health Holdings0 0 0 -
Is GTII.CX or WESA.X.CX More Risky?
Green Thumb Industries, Inc. has a beta of 0.833, which suggesting that the stock is 16.713% less volatile than S&P 500. In comparison Wesana Health Holdings has a beta of -1.000, suggesting its less volatile than the S&P 500 by 200.004%.
-
Which is a Better Dividend Stock GTII.CX or WESA.X.CX?
Green Thumb Industries, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Wesana Health Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Green Thumb Industries, Inc. pays -- of its earnings as a dividend. Wesana Health Holdings pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios GTII.CX or WESA.X.CX?
Green Thumb Industries, Inc. quarterly revenues are $401.3M, which are larger than Wesana Health Holdings quarterly revenues of --. Green Thumb Industries, Inc.'s net income of $32.8M is higher than Wesana Health Holdings's net income of --. Notably, Green Thumb Industries, Inc.'s price-to-earnings ratio is 41.09x while Wesana Health Holdings's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Green Thumb Industries, Inc. is 1.55x versus 0.39x for Wesana Health Holdings. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GTII.CXGreen Thumb Industries, Inc.1.55x 41.09x $401.3M $32.8M WESA.X.CXWesana Health Holdings0.39x -- -- --
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
60
AAOI alert for Dec 24
Applied Optoelectronics, Inc. [AAOI] is up 4.21% over the past day.
Buy
85
HUT alert for Dec 24
Hut 8 Corp. [HUT] is up 1.05% over the past day.
Buy
63
GPCR alert for Dec 24
Structure Therapeutics, Inc. [GPCR] is down 2.74% over the past day.
